Different effects of two aldose reductase inhibitors on nociception and prostaglandin E
- 1 October 1995
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 285 (2) , 189-197
- https://doi.org/10.1016/0014-2999(95)00402-7
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Tolrestat treatment prevents modification of the formalin test model of prolonged pain in hyperglycemic ratsPain, 1994
- Inhibition of Macrophage Chemotaxis and Peripheral Nerve Regeneration in Normal and Hyperglycemic Rats by the Aldose Reductase Inhibitor TolrestatExperimental Neurology, 1994
- Anti-nociceptive effects of the GM1 ganglioside derivative AGF 44 on the formalin test in normal and streptozotocin-diabetic ratsNeuroscience Letters, 1993
- Formalin-induced nociceptive responses in diabetic miceNeuroscience Letters, 1993
- Comparison of the Antinociceptive Effects of Pre- and Posttreatment with Intrathecal Morphine and MK801, an NMDA Antagonist, on the Formalin Test in the RatAnesthesiology, 1992
- Pain threshold in diabetic rats: effects of good versus poor diabetic controlPain, 1992
- Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: Antinociception in the absence of motor dysfunctionLife Sciences, 1991
- Aldose Reductase Inhibitors in the Treatment of Diabetic NeuropathyDrugs, 1990
- Deficient axonal transport of substance P in streptozocin-induced diabetic rats. Effects of sorbinil and insulinDiabetes, 1988
- Indomethacin blocks central nociceptive effects of PGF2αBrain Research, 1986